Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billion to EUR 2.09 billion

EQS-News: Brainlab AG / Key word(s): IPO Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billion to EUR 2.09 billion 23.06.2025 / 08:05 CET/CEST The issuer is solely responsible for the content of this announcement. PRESS RELEASE

 

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.

Price range set: Brainlab targets a market capitalization of c. EUR 1.67 billion to EUR 2.09 billion

 

• Price range set between EUR 80.00 to EUR 100.00 per share
• Proceeds of up to EUR 200 million from a capital increase will support the commercialization of fully integrated workflows and expansion into new clinical applications and adjacent market segments
• Sale of up to 3.2 million secondary shares from the holdings of existing shareholders, including an upsize option and potential over-allotment option, to ensure a significant free float of up to c. 26.6% and sufficient trading liquidity
• Offer period expected to commence on June 24, 2025 and expected to end on July 1, 2025; the first day of trading on the Prime Standard is planned for July 3, 2025
• Offering and listing are subject to approval of prospectus by German Federal Financial Supervisory Authority (BaFin) and prospectus publication

 

Munich, 23 June, 2025 – Brainlab AG, a software-first medtech company, has set the price range for its planned initial public offering at EUR 80.00 to EUR 100.00. The offering is expected to comprise 2.0 million new shares from a capital increase out of authorized capital and up to 3.2 million secondary shares held by entities of EMH, SV2019 GmbH, an investment vehicle of Stefan Vilsmeier and BMB Verwaltungsgesellschaft mbH. The free float after the IPO is expected to be up to c. 26.6%, subject to placement of all offer shares including the secondary upsize shares. Depending on the final offer price, the total placement volume is expected to be between EUR 368 million and EUR 460 million without the secondary upsize shares option and between EUR 416 million and EUR 520 million including the full exercise of the secondary upsize shares option, assuming in both cases the full exercise of the over-allotment option. With all shares placed, this would imply a market capitalization of between c. EUR 1.67 billion and EUR 2.09 billion. The first day of trading of Brainlab shares on the Regulated Market of the Frankfurt Stock Exchange (Prime Standard) is expected to begin on July 3, 2025.